All Pharma News
Nuvation Presents Taletrectinib ROS1 Inhibitor Data at ASCO

Nuvation Presents Taletrectinib ROS1 Inhibitor Data at ASCO
BUSINESSWIRE
24 Apr 2024
Share Share
Nuvation Bio Completes Acquisition of AnHeart Therapeutics

Nuvation Bio Completes Acquisition of AnHeart Therapeutics
BUSINESSWIRE
10 Apr 2024
Share Share
Nuvation Bio Announces Appointment of Colleen Sjogren as Chief CO

Nuvation Bio Announces Appointment of Colleen Sjogren as Chief CO
BUSINESSWIRE
28 Mar 2024
Share Share
Nuvation Bio nears commercial stage with AnHeart buy

Nuvation Bio nears commercial stage with AnHeart buy
Phil Taylor PHARMAPHORUM
26 Mar 2024
Share Share
Nuvation Bio to Acquire AnHeart Therapeutics in All-Stock Transaction

Nuvation Bio to Acquire AnHeart Therapeutics in All-Stock Transaction
BUSINESSWIRE
25 Mar 2024
Share Share
Nuvation Bio Doses First Patient in Phase 1/2 Study of NUV-1511

Nuvation Bio Doses First Patient in Phase 1/2 Study of NUV-1511
BUSINESSWIRE
14 Mar 2024
Share Share
Nuvation Bio Reports Fourth Quarter and Full Year 2023 Financial Results

Nuvation Bio Reports Fourth Quarter and Full Year 2023 Financial Results
BUSINESSWIRE
29 Feb 2024
Share Share
Nuvation Bio Announces FDA Clearance of Investigational NDA for NUV-1511

Nuvation Bio Announces FDA Clearance of Investigational NDA for NUV-1511
BUSINESSWIRE
08 Jan 2024
Share Share
Nuvation Announces Appointment of Dr. Robert Mashal to its Board of Directors

Nuvation Announces Appointment of Dr. Robert Mashal to its Board of Directors
BUSINESSWIRE
08 Jan 2024
Share Share
Nuvation Bio Announces Departure of Chief Financial Officer

Nuvation Bio Announces Departure of Chief Financial Officer
BUSINESSWIRE
13 Nov 2023
Share Share